Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M.

AIDS. 2004 Jan 1;18 Suppl 1:S19-25.

2.

Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.

Thaler NS, Sayegh P, Kim MS, Castellon SA, Hinkin CH.

Arch Clin Neuropsychol. 2015 Mar;30(2):114-21. doi: 10.1093/arclin/acu092.

3.

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M.

Neurology. 2002 Dec 24;59(12):1944-50.

4.

Aging, neurocognition, and medication adherence in HIV infection.

Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, Myers H, Wright MJ, Foley J.

Am J Geriatr Psychiatry. 2009 Apr;17(4):281-90. doi: 10.1097/JGP.0b013e31819431bd.

5.

Drug use and medication adherence among HIV-1 infected individuals.

Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, Myers HF, Longshore D.

AIDS Behav. 2007 Mar;11(2):185-94.

6.

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I; Hnrc Group And The Tmarc Group..

AIDS Care. 2012;24(12):1504-13. doi: 10.1080/09540121.2012.672718.

8.

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA.

AIDS Patient Care STDS. 2009 Jun;23(6):455-62. doi: 10.1089/apc.2008.0181.

9.

Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Meade CS, Conn NA, Skalski LM, Safren SA.

J Behav Med. 2011 Apr;34(2):128-38. doi: 10.1007/s10865-010-9293-5.

10.

Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.

Anderson AM, Higgins MK, Ownby RL, Waldrop-Valverde D.

AIDS Care. 2015;27(3):333-7. doi: 10.1080/09540121.2014.985183.

11.

Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.

Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, Santamaria EK, Bell J.

AIDS Care. 2009 Feb;21(2):168-77. doi: 10.1080/09540120802001705.

PMID:
19229685
12.

Longitudinal change in cognitive function and medication adherence in HIV-infected adults.

Becker BW, Thames AD, Woo E, Castellon SA, Hinkin CH.

AIDS Behav. 2011 Nov;15(8):1888-94. doi: 10.1007/s10461-011-9924-z.

13.

Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, Levine AJ, Durvasula RS.

Health Psychol. 2007 Jan;26(1):40-9.

14.

Structure of a cognitive ability battery among HIV+ intravenous drug users evaluated in a study of medication adherence.

Ownby RL, Kumar M, Waldrop-Valverde D.

Int J Neurosci. 2005 Sep;115(9):1259-71.

PMID:
16048805
15.

Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Norman LR, Basso M, Kumar A, Malow R.

Curr Drug Abuse Rev. 2009 May;2(2):143-56. Review.

PMID:
19630745
16.

The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.

Waldrop-Valverde D, Jones DL, Weiss S, Kumar M, Metsch L.

AIDS Care. 2008 Nov;20(10):1202-10. doi: 10.1080/09540120801927017.

PMID:
19012081
17.

Assessment and predictors of antiretroviral adherence in older HIV-infected patients.

Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S106-14.

PMID:
12853859
18.

Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.

Meade CS, Towe SL, Skalski LM, Robertson KR.

Drug Alcohol Depend. 2015 Apr 1;149:128-35. doi: 10.1016/j.drugalcdep.2015.01.034.

19.

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.

Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE; HER Study Group..

AIDS. 2002 Nov 8;16(16):2175-82.

PMID:
12409739
20.

Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Anand P, Springer SA, Copenhaver MM, Altice FL.

AIDS Behav. 2010 Dec;14(6):1213-26. doi: 10.1007/s10461-010-9684-1. Review.

Items per page

Supplemental Content

Support Center